Liaoning Cheng Da Co., Ltd. (SHA:600739)
10.69
+0.25 (2.39%)
Apr 1, 2025, 2:45 PM CST
Liaoning Cheng Da Revenue
Liaoning Cheng Da had revenue of 2.89B CNY in the quarter ending September 30, 2024, a decrease of -6.52%. This brings the company's revenue in the last twelve months to 11.29B, up 8.71% year-over-year. In the year 2023, Liaoning Cheng Da had annual revenue of 10.78B, down -25.97%.
Revenue (ttm)
11.29B
Revenue Growth
+8.71%
P/S Ratio
1.41
Revenue / Employee
3.37M
Employees
3,356
Market Cap
15.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.78B | -3.78B | -25.97% |
Dec 31, 2022 | 14.56B | -3.81B | -20.73% |
Dec 31, 2021 | 18.37B | 1.43B | 8.43% |
Dec 31, 2020 | 16.94B | -800.78M | -4.51% |
Dec 31, 2019 | 17.75B | -1.53B | -7.94% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |